{
    "title": "Variant Alleles of the",
    "journal": "Frontiers in Endocrinology",
    "publication_date": "2018",
    "abstract": "Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age, with a prevalence of 6\u20138%. Although the etiology of PCOS has been investigated extensively, the association between genetic predisposition and PCOS risk is largely unknown. In this study, we genotyped 63 SNPs in 10 genes among 361 PCOS patients and 331 healthy controls in a Chinese Han population. The following variant alleles were significantly associated with decreased PCOS risk:",
    "body": "Introduction  Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age, with a prevalence of 6\u20138% ( 1 ). This syndrome is characterized by hyperandrogenism, amenorrhea or oligomenorrhea and polycystic ovaries ( 2 , 3 ). Women with PCOS are potentially at elevated risk of multiple diseases and disorders, including infertility ( 4 ), insulin resistance ( 5 ), obesity ( 6 ), premature carotid arteriosclerosis ( 7 ), type 2 diabetes mellitus ( 8 ), and mood disorders, such as depression and anxiety ( 9 , 10 ). Epidemiological studies suggest that androgen excess, lifestyle ( 11 ), ovulatory dysfunction, alteration in intrauterine environment ( 12 ), adipose tissue dysfunction and gonadotropin abnormalities can contribute to PCOS risk ( 13 ). The etiology of PCOS is complicated and not well elucidated.  A substantial body of evidence has implicated various genetic factors in PCOS development ( 14 ). Related studies have been conducted on at least 70 genes, which roles are involved in the main process of this disease, such as steroid synthesis ( CYP11A1 and CYP19A1 ) ( 15 ), steroid action ( ESR1, ESR2 , and PGR ) ( 16 ), lipid metabolism ( PPARG and MTHFR ) ( 17 \u2013 19 ), insulin action ( HMGA2 ) ( 20 ) and embryonic development ( SUMO1P1 ) ( 21 , 22 ) have been implicated in PCOS. However, the heterogeneity and generalizability of these genetic associations are not enough to explain clearly the considerable genetic susceptibility for this endocrine-metabolic disorder. For example, FSHR rs6166 was associated with increased PCOS risk in a study of 377 Chinese PCOS patients and 388 age-matched healthy controls ( 23 ), but not in a study in a different ethnic population ( 24 ). ESR1 rs9340799 has been associated with increased PCOS risk in a Pakistani population ( 25 ), but not in a Brazilian population ( 26 ).  Therefore, finding as many single-nucleotide polymorphisms (SNPs) as possible through population studies will provide valuable assistance to clinicians and patients. Except for the previous reported genes which are involved in the pathogenesis of PCOS, morphological changes in the ovary is a key part in the development of PCOS. Related studies have proved that LAMC1 can promote the development of follicles ( 27 ) and some SNP polymorphisms were significantly associated with premature ovarian failure (POF) ( 28 ). Because of the role of follicular development in the development of PCOS, the association between LAMC1 polymorphism and PCOS risk deserved studying.  Considering the important role of genetic factors in this pathogenesis of PCOS, the aim of the study was to discover some genetic variations associated with these abnormal pathological mechanisms. So we have chosen several sites in CYP11A1, CYP19A1, ESR1, ESR2, PGR, PPARG, LAMC1, HMGA2, MTHFR , and SUMO1P1 as our research object according to the functional description in the literature. We genotyped for 63 SNPs including 40 which had never been assessed for their potential association with PCOS in 10 known pathogenicity-causing genes by a case-control study of 361 PCOS cases and 331 controls in a Chinese population.    Materials and methods   Sample collection  A total of 361 PCOS patients and 331 controls, all of Han Chinese ethnicity, were included in this multi-center study. Subjects were recruited between January 2015 and February 2017 at the Reproductive Hospital Affiliated to Shandong University, at the Women's Hospital of the School of Medicine of Zhejiang University and at the Renji Hospital Affiliated to Shanghai Jiao Tong University. PCOS was diagnosed based on the NIH criteria [National Institutes of Health/National Institute of Child Health and Human Development (NIH/NICHD) in April 1990], including biochemical and/or clinical hyperandrogenism and ovulatory dysfunction, after the exclusion of related or other disorders ( 1 ). This study was approved by the Shanghai Xinhua Hospital Research Ethics Board and all subjects gave their informed consent for inclusion before they participated in the study. Women were excluded if they had been diagnosed with 21-hydroxylase-deficiency, androgen-producing tumors, hyperprolactinemia, non-classical adrenal hyperplasia, Cushing's syndrome, and active thyroid disease, since these conditions likely affect reproductive physiology ( 19 , 29 ). All the controls were defined as women with normal hormonal status and regular menstrual cycles at intervals of 28\u201335 days. Information on participants was collected from medical records.    Biochemical and hormonal analyses  Peripheral blood samples were taken from participants in a fasting state on days 3\u20135 of the menstrual cycle. Blood samples were collected into EDTA anticoagulant tubes, centrifuged, and stored at \u221280\u00b0C. Levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone (T), and estradiol (E 2 ) were measured using a chemiluminescent analyzer (Beckman Coulter, Fullerton, CA, USA). The limit of detection (LOD) of LH, FSH, T and E2 was 0.1 IU/L, 0.1 IU/L, 0.1 nmol/L and 0.1 pg/ml respectively. They intra- and inter-assay coefficients of variations (CV) were < 6% and < 10%, respectively.    SNP selection and genotyping  A total of 63 SNPs were selected in the following 10 genes, mainly based on literature review: CYP11A1, CYP19A1, ESR1, ESR2, PGR, PPARG, MTHFR, HMGA2, LAMC1 , and SUMP1O1 ( 21 ). Five of the SNPs were 3\u2032-flanking variants; 57 SNPs, intronic variants; 3 SNPs in exons, non-synonymous variants; 3 SNPs in exons, synonymous variants; and 2 SNPs near 5\u2032-flanking regions. Genomic DNA was extracted from the buffy coat using DNA isolation kits (TIANGEN, China) according to the manufacturer's protocol. Genotyping was carried out using polymerase chain reaction ligation detection reaction (PCR-LDR). Genotyping was performed by technicians blinded to case or control status. In addition, 5% of samples were re-genotyped, and the results agreed 100% with the first results. PCRs were carried out on an ABI 7300 (Applied Biosystem, Foster City, CA, USA) in a total volume of 20 \u03bcl including 20 ng genomic DNA, 2.5 mM MgCl2, 0.2 mM dNTPs, 0.5 \u03bcM each primer, 1 \u00d7 PCR Buffer and 1 U Hot-Start Taq DNA polymerase (QIAgen). Cycling parameters were set as follows: 95\u00b0C for 10 min, 38 cycles at 94\u00b0C for 15 s, 60\u00b0C for 1.5 min, 72\u00b0C for 60 s, followed by 72\u00b0C for 10 min. The ligation reaction was carried out in a final volume of 20 \u03bcl containing 2 \u03bcl template DNA, 1 \u03bcl 10 \u00d7 ligation buffer, 20 U Taq DNA ligase and 1 pmol of each discriminating probe (New England Biolabs, USA). The LDR parameters were as follows: 94\u00b0C for 1.5 min, 35 cycles at 94\u00b0C for 15 s and 58\u00b0C for 1.5 min. Following the LDR reaction, 1 \u03bcl LDR reaction product was mixed with 1 \u03bcl loading buffer as well as 1 \u03bcl ROX. The mixture was then analyzed using the ABI 7900HT (Applied Biosystems).    Statistical analysis  Hormone levels, differences in age and body mass index (BMI) between controls and cases were evaluated using Student's t -test. The fit of results for each SNP in controls was assessed against expectations based on Hardy-Weinberg equilibrium (HWE) using the \u03c7 2 -test. Associations between selected polymorphisms and PCOS were assessed using unconditional logistic regression with adjustment for BMI and age.  Pairwise linkage disequilibrium (LD) among the selected SNPs was examined using Lewontin's standardized coefficient D' and LD coefficient r 2 ( 30 ). Haplotype blocks were defined by the method of ( 31 ) in the publicly available Haploview software ( www.broadinstitute.org/haploview/downloads ) using default settings: the confidence interval for a strong LD was minimal for upper 0.98 and low 0.7 and maximal for a strong recombination of 0.9, and a fraction of strong LD in informative comparisons was at least 0.95. Haplotype analysis was performed using the SNP stats tool ( www.snpstats.net/snpstats/start.htm?q=snpstats/start.htm ), with adjustment for age and BMI where appropriate. Multiple test corrections were performed for each gene using Bonferroni correction. All statistical analyses were performed using SAS 9.4 software and R. P < 0.05 was considered statistically significant.     Results   Characteristics of the participants  The characteristics of the participants are shown in Table 1 . The age of cases ranged from 19 to 40 years (mean \u00b1 SD, 28.1 \u00b1 3.7); the age of controls, from 22 to 45 years (28.4 \u00b1 4.2, P = 0.041). As expected, levels of LH, testosterone and BMI in the PCOS group were significantly higher than that in healthy controls.   Table 1   Characteristics of participants.       Characteristic    Controls ( n = 331)    Cases ( n = 361)     P a        Age (years)  28.4 \u00b1 4.2  28.1 \u00b1 3.7  0.364    BMI (kg/m 2 )  21.5 \u00b1 3.4  24.9 \u00b1 4.3  < 0.0001    < 24  282 (85.2%)  169 (46.8)     \u226524  49 (14.8%)  192 (53.2)     LH (IU/L)  4.1 \u00b1 4.7  7.0 \u00b1 5.8  < 0.0001    FSH (IU/L)  4.1 \u00b1 3.6  5.4 \u00b1 2.6   0.0002     LH/FSH  0.6 \u00b1 0.7  1.2 \u00b1 1.1  < 0.0001    T (nmol/L)  2.8 \u00b1 3.1  23.7 \u00b1 23.4  < 0.0001    E 2 (pg/ml)  88.2 \u00b1 75.3  104.7 \u00b1 165.8  0.775      Continuous data were expressed as mean \u00b1 SD; BMI, body mass index; LH, luteinizing hormone; FSH, follicle-stimulating hormone; T, testosterone; E 2 , estradiol .   a  Boldface indicates P < 0.05 .       Association between individual SNPs and PCOS risk  Results on minor allele frequencies and HWE at selected SNPs are shown in Table 2 . Among the 63 polymorphisms, five deviated from HWE ( P < 0.05): rs1801132, rs1884051, rs722208, rs932477, and rs728524. Minor allele frequencies of 0 were observed for the following five SNPs: rs1913474, rs1042839, rs480851, rs1805192, and rs709150. These 10 SNPs were excluded from subsequent analysis. Among 53 polymorphic locus analysis, we found that the following variant alleles were significantly associated with decreased PCOS risk: The A>G allele distributions at rs9340799 in ESR1 ( P = 0.000), the A>T at rs709154 ( P = 0.013), and A>C at rs1151996 ( P = 0.013) in PPARG . the A>C at rs2272046 in HMGA2 ( P = 0.000), and the T>C at rs1801133 in MTHFR ( P = 0.000, Table 3 ). Further we detected the following genotype distribution were associated with decreased PCOS risk: GA genotype at rs9340799 ( P < 0.0001) in ESR1 , TA genotype at rs709154 ( P < 0.0001) in PPARG , CA genotype at rs2272046 ( P < 0.0001) in HMGA2 . Moreover, GA genotype at rs1999805 ( P = 0.013) in ESR1 and TT genotype at rs1801133 in MTHFR ( P < 0.0001) correlated with elevated PCOS risk (Table 4 ). We conducted a stratified analysis of risk-related loci by BMI (BMI < 24, BMI \u2265 24; Supplementary Table 1 ). Finally we found that BMI may not affect the risk of rs9340799 and rs1999805 in ESR1 , rs2272046 in HMGA2 , rs1801133 in MTHFR , rs709154 in PPARG gene and PCOS.   Table 2   Information about minor allele frequency and Hardy-Weinberg equilibrium at selected SNPs.       Gene    SNP    Genomic position    Position in gene    MAF    HWE    Genotyping            Rate (%)        CYP11A1   rs9806234  74663033  Intron  0.35  0.19  96.3     rs11632698  74637867  Intron  0.25  0.47  99.2     rs11638442  74634899  Intron  0.25  0.62  99.6     rs16968478  74662811  Intron  0.45  0.12  97.2     rs1843090  74643034  Intron  0.41  0.69  96.5     rs2073475  74661894  5\u2032 near gene  0.41  0.56  97.8     rs2279357  74630623  Intron  0.41  0.56  97.4     rs4887139  74661945  5\u2032 near gene  0.1  1.00  97.2     rs7173655  74632362  Intron  0.4  0.43  97.9     CYP19A1   rs2414096  51529779  Intron  0.47  0.70  96.5     rs700518  51529112  Synonymous exon  0.47  1.00  96.7     ESR1   rs1709183  152193996  Intron  0.41  0.56  98.4     rs1801132  152265522  Synonymous exon  0.48   0.00   b    98.4     rs1884051  152283279  Intron  0.47   0.01   b    98.2     rs2228480  152420095  Intron  0.26  0.06  97.9     rs2234693  152163335  Intron  0.41  0.69  98.9     rs3020314  152270672  Intron  0.14  0.07  100.0     rs3778082  152387664  Intron  0.33  0.52  97.4     rs3778099  152418575  Intron  0.37  0.22  97.2     rs3798573  152389362  Intron  0.34  0.40  96.9     rs3798577  152421130  Intron  0.46  0.33  98.4     rs722208  152322885  Intron  0.49   0.01   b    97.8     rs851982  152024985  Intron  0.13  0.60  96.7     rs9322331  152162317  Intron  0.03  1.00  98.8     rs932477  152304596  Intron  0.39   0.01   b    99.4     rs9340799  152163381  Intron  0.19  0.61  96.9     rs1913474  152208722  Intron   0.00   a    1.00  23.4     rs1999805  152068364  Intron  0.33  0.23  97.4     rs728524  152303437  Intron  0.21   0.02   b    97.9     ESR2   rs1255998  64693871  3\u2032 utr  0.48  0.55  96.3     rs928554  64694195  3\u2032 utr  0.66  0.31  97.9     rs960070  64745179  Intron  0.25  1.00  94.3     rs1152579  64695087  Intron  0.3  0.83  96.7     rs944459  64699358  Intron  0.27  0.10  97.9     PGR   rs1042839  100922202  Synonymous exon   0.00   a    1.00  100     rs471767  100905297  3\u2032 utr  0.05  1.00  99.8     rs484389  100909809  3\u2032 utr  0.16  0.26  96.7     rs508653  100962200  Intron  0.15  0.06  98.9     rs547378  100922939  Intron  0.16  0.26  99.4     rs561650  100915894  Intron  0.14  0.69  98.4     rs566351  100985014  Intron  0.15  0.42  98.2     rs572483  100967572  Intron  0.15  0.07  97.6     rs613120  100974278  Intron  0.15  0.06  98.6     rs480851  100976191  Intron   0.00   a    1.00  98.9     rs500760  100909991  Synonymous exon  0.16  0.26  97.3     rs608995  100905733  3\u2032 utr  0.16  0.26  96.7     PPARG   rs1801282  12393125  Intron  0.06  1.00  99.1     rs1805192  12421238  Non-synonymous exon   0.00   a    1.00  100     rs709149  12450354  Intron  0.43  0.51  95.5     rs709150  12451337  Intron   0.00   a    1.00  28.2     rs709151  12454999  Intron  0.39  0.18  98.2     rs709154  12456834  Intron  0.36  0.25  98.6     rs1151996  12445807  Intron  0.47  1.00  98.2     LAMC1   rs1413390  183096634  Intron  0.45  0.55  95.9     rs1537520  183084229  Intron  0.45  0.43  98.2     rs20558  183094547  Non-synonymous exon  0.47  0.24  98.6     rs2296293  183095477  Intron  0.45  0.16  96.5     rs2296300  183099701  Intron  0.45  0.33  98.8     rs6424888  183085696  Intron  0.45  0.33  98.8     rs6672093  183079853  Intron  0.47  0.43  98.6     HMGA2   rs2272046  66224461  Intron  0.07  0.21  99.8     MTHFR   rs1801133  11856378  Non-synonymous exon  0.47  0.42  92.7     SUMO1P1   rs6022786  52447303  Intron  0.33  0.54  96.7       a  Boldface is used for minor allele frequencies of 0 .    b  Boldface for deviation from HWE .   SNP, single-nucleotide polymorphism; MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium, HWE P value in the control group .     Table 3   Allele frequencies of the selected genetic variants analyzed in PCOS patients and controls.      No .   Gene    SNP    Base    OR (95%CI)     P   a       P ajusted          Change          1   CYP11A1   rs9806234  G>A  1.15(0.88,1.50)  0.299  0.474    2   rs11632698  A>G  0.87(0.66,1.14)  0.311  0.479    3   rs11638442  C>G  0.89(0.67,1.17)  0.393  0.593    4   rs16968478  A>G  0.97(0.76,1.22)  0.779  0.874    5   rs1843090  G>A  0.91(0.71,1.17)  0.475  0.684    6   rs2073475  C>T  0.77(0.60,0.99)  0.042  0.150    7   rs2279357  C>T  0.91(0.71,1.17)  0.480  0.685    8   rs4887139  A>G  2.10(1.36,3.26)  0.001  0.068    9   rs7173655  C>T  0.97(0.75,1.26)  0.832  0.908    10   CYP19A1   rs2414096  G>A  1.15(0.91,1.45)  0.251  0.419    11   rs700518  T>C  1.06(0.83,1.34)  0.664  0.783    12   ESR1   rs1709183  C>T  1.02(0.79,1.31)  0.900  0.955    13   rs2228480  G>A  1.46(1.08,1.98)  0.013  0.079    14   rs2234693  T>C  1.03(0.80,1.32)  0.840  0.910    15   rs3020314  C>T  0.71(0.49,1.04)  0.081  0.218    16   rs3778082  G>A  0.76(0.58,1.00)  0.053  0.166    17   rs3778099  T>C  0.92(0.68,1.25)  0.594  0.740    18   rs3798573  A>G  0.74(0.57,0.97)  0.027  0.121    19   rs3798577  T>C  0.67(0.51,0.87)  0.003  0.124    20   rs851982  T>C  1.68(1.14,2.47)  0.008  0.218    21   rs9322331  C>T  1.46(0.70,3.04)  0.314  0.479    22   rs9340799  A>G  0.50(0.37,0.67)  0.000   0.000     23   rs1999805  G>A  1.22(0.95,1.57)  0.123  0.280    24   ESR2   rs1255998  C>G  1.05(0.83,1.33)  0.656  0.783    25   rs928554  T>C  0.83(0.63,1.08)  0.159  0.324    26   rs960070  G>C  1.36(1.01,1.84)  0.042  0.150    27   rs1152579  G>A  0.75(0.58,0.98)  0.036  0.135    28   rs944459  C>T  0.90(0.69,1.17)  0.430  0.643    29   PGR   rs471767  A>G  1.19(0.68,2.09)  0.538  0.716    30   rs484389  A>G  1.46(1.04,2.06)  0.030  0.124    31   rs508653  C>A  1.35(0.96,1.91)  0.085  0.222    32   rs547378  G>A  1.49(1.06,2.09)  0.022  0.102    33   rs561650  T>C  1.50(1.04,2.17)  0.031  0.125    34   rs566351  C>T  1.42(0.99,2.01)  0.053  0.166    35   rs572483  T>C  1.31(0.93,1.84)  0.117  0.274    36   rs613120  A>G  1.29(0.92,1.81)  0.143  0.299    37   rs500760  T>C  1.45(1.03,2.04)  0.032  0.126    38   rs608995  A>T  1.50(1.07,2.11)  0.019  0.095    39   PPARG   rs1801282  C>G  0.56(0.35,0.91)  0.020  0.095    40   rs709149  G>A  0.87(0.66,1.14)  0.311  0.479    41   rs709151  C>T  0.72(0.56,0.94)  0.017  0.092    42   rs709154  A>T  0.65(0.50,0.85)  0.001   0.013     43   rs1151996  A>C  0.66(0.51,0.85)  0.001   0.013     44   LAMC1   rs1413390  A>G  1.19(0.92,1.53)  0.191  0.346    45   rs1537520  T>C  1.19(0.92,1.55)  0.180  0.340    46   rs20558  C>T  1.18(0.91,1.53)  0.209  0.361    47   rs2296293  A>G  1.26(0.97,1.65)  0.082  0.218    48   rs2296300  A>G  1.18(0.91,1.53)  0.213  0.363    49   rs6424888  G>A  1.18(0.91,1.53)  0.204  0.356    50   rs6672093  C>T  1.15(0.89,1.49)  0.274  0.443    51   HMGA2   rs2272046  A>C  0.28(0.18,0.43)  0.000   0.000     52   MTHFR   rs1801133  T>C  0.62(0.49,0.80)  0.000   0.000     53   SUMO1P1   rs6022786  G>A  0.74(0.57,0.95)  0.019  0.095      Boldface indicates P < 0.05; CI, confidence interval; OR, odds ratio; SNP, single-nucleotide polymorphism; PCOS, polycystic ovarian syndrome .   a  P-value from unconditional logistic regression with adjustment for BMI and age .   P ajusted were performed for each gene using Bonferroni correction .     Table 4   Genotype frequencies of selected polymorphisms analyzed in PCOS patients and controls.       Gene    SNP    Controls    Cases    OR (95%CI)     P   a       P ajusted         ( n = 331)    ( n = 361)           CYP11A1   rs9806234          G/G  124 (40.0)  139 (40.1)  Reference       G/A  156(50.3)  167 (48.1)  1.02(0.71\u20131.46)  0.926  0.974     A/A  30 (9.7)  41 (11.8)  1.50(0.83\u20132.69)  0.178  0.340     rs11632698          A/A  160 (50.2)  192 (53.6)  Reference       A/G  135 (42.3)  152 (42.5)  0.96 (0.68\u20131.36)  0.830  0.908     G/G  24 (7.5)  14 (3.9)  0.60 (0.28\u20131.25)  0.170  0.340     rs11638442          C/C  160 (50.8)  194 (53.7)  Reference       C/G  131 (41.6)  153 (42.4)  1.01 (0.71\u20131.44)  0.943  0.974     G/G  24 (7.6)  14 (3.9)  0.59 (0.28\u20131.23)  0.158  0.324     rs16968478          A/A  67 (20.6)  104 (29.7)  Reference       G/A  202 (62.0)  190 (54.3)  0.59 (0.39\u20130.88)  0.010  0.068     G/G  57 (17.5)  56 (16.0)  0.55 (0.32\u20130.94)  0.028  0.122     rs1843090          G/G  102 (32.5)  125 (35.7)  Reference       G/A  162 (51.6)  172 (49.1)  0.81 (0.56\u20131.18)  0.266  0.435     A/A  50 (15.9)  53 (15.1)  0.89 (0.53\u20131.48)  0.652  0.783     rs2073475          C/C  92 (28.3)  122 (34.7)  Reference       C/T  181 (55.7)  182 (51.7)  0.76 (0.52\u20131.10)  0.142  0.299     T/T  52 (16.0)  48 (13.6)  0.60 (0.35\u20131.01)  0.055  0.169     rs2279357          C/C  102 (30.8)  119 (34.1)  Reference       T/C  179 (54.1)  179 (51.3)  0.80 (0.55\u20131.16)  0.243  0.410     T/T  50 (15.1)  51 (14.6)  0.89 (0.53\u20131.50)  0.675  0.785     rs4887139          A/A  280 (87.2)  278 (79.0)  Reference       G/A  41 (12.8)  69 (19.6)  1.91 (1.21\u20133.04)  0.006  0.055     G/G  0 (0.0)  5 (1.4)  NA  0.977  0.980     rs7173655          C/C  101 (30.6)  113 (32.1)  Reference       C/T  186 (56.4)  189 (53.7)  0.95 (0.65\u20131.38)  0.777  0.874     T/T  43 (13.0)  50 (14.2)  0.96 (0.56\u20131.65)  0.888  0.948     CYP19A1   rs2414096          G/G  106 (34.0)  99 (28.3)  Reference       G/A  131 (42.0)  174 (49.7)  1.40 (0.94\u20132.08)  0.100  0.249     A/A  75 (24.0)  77 (22.0)  1.28 (0.80\u20132.04)  0.304  0.477     rs700518          T/T  90 (29.9)  100 (28.4)  Reference       T/C  143 (47.5)  177 (50.3)  1.05 (0.70\u20131.58)  0.801  0.892     C/C  68 (22.6)  75 (21.3)  1.11 (0.68\u20131.81)  0.668  0.783     ESR1   rs1709183          C/C  97 (29.5)  121 (34.1)  Reference       T/C  189 (57.4)  178 (50.1)  0.75 (0.52\u20131.09)  0.133  0.294     T/T  43 (13.1)  56 (15.8)  1.22 (0.72\u20132.08)  0.460  0.675     rs2228480          G/G  194 (60.8)  186 (52.4)  Reference       G/A  116 (36.4)  153 (43.1)  1.46 (1.03\u20132.07)  0.034  0.130     A/A  9 (2.8)  16 (4.5)  2.18 (0.86\u20135.55)  0.102  0.250     rs2234693          T/T  102 (32.5)  111 (30.9)  Reference       T/C  158 (50.3)  198 (55.2)  1.11 (0.76\u20131.63)  0.576  0.735     C/C  54 (17.2)  50 (13.9)  1.02 (0.61\u20131.71)  0.941  0.974     rs3020314          C/C  235 (71.0)  271 (75.1)  Reference       T/C  96 (29.0)  90 (24.9)  0.72 (0.49\u20131.04)  0.081  0.218     rs3778082          G/G  129 (42.4)  164 (46.2)  Reference       G/A  146 (48.0)  158 (44.5)  0.70 (0.48\u20131.02)  0.061  0.184     A/A  29 (9.5)  33 (9.3)  0.65 (0.34\u20131.22)  0.176  0.340     rs3778099          T/T  37 (34.9)  137 (36.9)  Reference       C/T  57 (53.8)  195 (52.6)  0.84 (0.51\u20131.49)  0.511  0.710     C/C  12 (11.3)  39 (10.5)  0.84 (0.37\u20131.86)  0.659  0.783     rs3798573          A/A  126 (40.5)  157 (44.9)  Reference       A/G  154 (49.5)  160 (45.7)  0.70 (0.49\u20131.00)  0.051  0.166     G/G  31 (10.0)  33 (9.4)  0.58 (0.31\u20131.08)  0.089  0.229     rs3798577          C/C  72 (22.4)  52 (14.5)  Reference       T/C  184 (57.3)  206 (57.5)  1.48 (0.94\u20132.33)  0.092  0.233     T/T  65 (20.2)  100 (27.9)  2.23 (1.32\u20133.78)  0.003  0.124     rs851982          T/T  266 (81.6)  258 (74.1)  Reference       T/C  60 (18.4)  83 (23.9)  1.51 (1.00\u20132.27)  0.047  0.164     C/C  0 (0.0)  7 (2.0)  NA  0.973  0.980     rs9322331          C/C  315 (96.0)  336 (94.1)  Reference       T/C  13 (4.0)  20 (5.6)  1.31 (0.60\u20132.85)  0.503  0.705     T/T  0 (0.0)  1 (0.3)  NA  0.980  0.980     rs9340799          A/A  159 (48.8)  243 (69.6)  Reference       G/A  144 (44.2)  93 (26.6)  0.40 (0.28\u20130.58)  < 0.0001  < 0.0001     G/G  23 (7.1)  13 (3.7)  0.45 (0.20\u20131.00)  0.049  0.164     rs1999805          G/G  167 (53.9)  140 (39.7)  Reference       G/A  103 (33.2)  178 (50.4)  1.91 (1.32\u20132.75)  0.001   0.013      A/A  40 (12.9)  35 (9.9)  0.98 (0.56\u20131.72)  0.953  0.978     ESR2   rs1255998          C/C  90 (29.7)  104 (29.5)  Reference       C/G  146 (48.2)  161 (45.7)  0.99 (0.66\u20131.48)  0.959  0.978     G/G  67 (22.1)  87 (24.7)  1.12 (0.70\u20131.80)  0.630  0.773     rs928554          T/T  128 (41.7)  179 (50.0)  Reference       C/T  148 (48.2)  152 (42.5)  0.89 (0.63\u20131.27)  0.523  0.716     C/C  31 (10.1)  27 (7.5)  0.60 (0.32\u20131.15)  0.124  0.280     rs960070          G/G  194 (63.8)  179 (52.5)  Reference       G/C  99 (32.6)  141 (41.3)  1.33 (0.92\u20131.91)  0.125  0.280     C/C  11 (3.6)  21 (6.2)  2.03 (0.85\u20134.85)  0.110  0.262     rs1152579          G/G  128 (40.6)  184 (52.4)  Reference       G/A  154 (48.9)  141 (40.2)  0.77 (0.54\u20131.09)  0.141  0.299     A/A  33 (10.5)  26 (7.4)  0.55 (0.29\u20131.04)  0.065  0.189     rs944459          C/C  156 (49.4)  201 (56.3)  Reference       C/T  139 (44.0)  129 (36.1)  0.77 (0.54\u20131.09)  0.136  0.297     T/T  21 (6.6)  27 (7.6)  1.06 (0.55\u20132.04)  0.868  0.933     PGR   rs471767          A/A  299 (90.3)  325 (90.3)  Reference       A/G  32 (9.7)  35 (9.7)  1.19 (0.68\u20132.09)  0.534  0.716     rs484389          A/A  262 (79.2)  248 (70.9)  Reference       A/G  61 (18.4)  95 (27.1)  1.67 (1.12\u20132.49)  0.013  0.079     G/G  8 (2.4)  7 (2.0)  1.14 (0.34\u20133.76)  0.833  0.908     rs508653          C/C  267 (81.2)  264 (73.7)  Reference       C/A  53 (16.1)  84 (23.5)  1.84 (1.20\u20132.81)  0.005  0.051     A/A  9 (2.7)  10 (2.8)  0.68 (0.25\u20131.88)  0.457  0.684     rs547378          G/G  262 (79.2)  253 (70.7)  Reference       G/A  61 (18.4)  97 (27.1)  1.69 (1.14\u20132.53)  0.010  0.068     A/A  8 (2.4)  8 (2.2)  1.22 (0.38\u20133.87)  0.735  0.836     rs561650          T/T  265 (80.1)  262 (74.0)  Reference       T/C  64 (19.3)  85 (24.0)  1.44 (0.96\u20132.15)  0.077  0.216     C/C  2 (0.6)  7 (2.0)  3.33 (0.59\u201318.9)  0.174  0.340     rs566351          C/C  260 (79.5)  256 (72.1)  Reference       C/T  62 (19.0)  89 (25.1)  1.51 (1.00\u20132.27)  0.049  0.164     T/T  5 (1.5)  10 (2.8)  1.46 (0.44\u20134.85)  0.538  0.716     rs572483          T/T  263 (79.9)  259 (73.4)  Reference       C/T  57 (17.3)  83 (23.5)  1.70 (1.12\u20132.58)  0.013  0.079     C/C  9 (2.7)  11 (3.1)  0.76 (0.28\u20132.05)  0.588  0.739     rs613120          A/A  265 (80.1)  262 (73.8)  Reference       A/G  57 (17.2)  82 (23.1)  1.66 (1.09\u20132.52)  0.017  0.092     G/G  9 (2.7)  11 (3.1)  0.75 (0.28\u20132.01)  0.561  0.734     rs500760          T/T  262 (79.2)  247 (70.6)  Reference       C/T  61 (18.4)  95 (27.1)  1.63 (1.09\u20132.44)  0.017  0.092     C/C  8 (2.4)  8 (2.3)  1.25 (0.39\u20133.99)  0.702  0.810     rs608995          A/A  258 (78.9)  244 (69.7)  Reference       T/A  61 (18.7)  98 (28.0)  1.71 (1.15\u20132.56)  0.008  0.063     T/T  8 (2.4)  8 (2.3)  1.24 (0.39\u20133.93)  0.711  0.815     PPARG   rs1801282          C/C  271 (83.4)  321 (89.2)  Reference       C/G  54 (16.6)  39 (10.8)  0.56 (0.35\u20130.91)  0.020  0.095     rs709149          G/G  95 (30.0)  132 (37.9)  Reference       G/A  177 (55.8)  176 (50.6)  0.73 (0.50\u20131.07)  0.108  0.261     A/A  45 (14.2)  40 (11.5)  0.86 (0.48\u20131.54)  0.621  0.768     rs709151          C/C  85 (26.2)  133 (37.6)  Reference       T/C  189 (58.3)  182 (51.4)  0.61 (0.42\u20130.89)  0.009  0.067     T/T  50 (15.4)  39 (11.0)  0.60 (0.34\u20131.04)  0.069  0.197     rs709154          A/A  90 (27.5)  156 (43.9)  Reference       T/A  187 (57.2)  160 (45.1)  0.47 (0.33\u20130.69)  < 0.0001  < 0.0001     T/T  50 (15.3)  39 (11.0)  0.54 (0.31\u20130.94)  0.030  0.124     rs1151996          A/A  88 (27.2)  125 (35.9)  Reference       C/A  154 (47.7)  182 (52.3)  0.81 (0.55\u20131.19)  0.285  0.457     C/C  81 (25.1)  41 (11.8)  0.40 (0.24\u20130.68)  0.010  0.068     LAMC1   rs1413390          A/A  97 (30.5)  88 (25.4)  Reference       G/A  174 (54.7)  195 (56.4)  1.14 (0.77\u20131.70)  0.501  0.705     G/G  47 (14.8)  63 (18.2)  1.43 (0.85\u20132.40)  0.184  0.344     rs1537520          T/T  97 (29.5)  88 (24.8)  Reference       C/T  185 (56.2)  206 (58.0)  1.15 (0.78\u20131.71)  0.473  0.684     C/C  47 (14.3)  61 (17.2)  1.44 (0.85\u20132.44)  0.174  0.34     rs20558          C/C  96 (29.2)  88 (24.6)  Reference       T/C  187 (56.8)  208 (58.3)  1.12 (0.75\u20131.65)  0.585  0.739     T/T  46 (14.0)  61 (17.1)  1.42 (0.84\u20132.41)  0.192  0.346     rs2296293          A/A  97 (30.1)  87 (25.0)  Reference       A/G  183 (56.8)  201 (57.8)  1.13 (0.76\u20131.69)  0.536  0.716     G/G  42 (13.0)  60 (17.2)  1.67 (0.97\u20132.86)  0.065  0.189     rs2296300          A/A  97 (29.3)  89 (25.0)  Reference       A/G  187 (56.5)  206 (57.9)  1.12 (0.76\u20131.66)  0.570  0.735     G/G  47 (14.2)  61 (17.1)  1.41 (0.83\u20132.39)  0.199  0.351     rs6424888          G/G  97 (29.3)  88 (24.6)  Reference       G/A  187 (56.5)  207 (58.0)  1.12 (0.76\u20131.66)  0.559  0.734     A/A  47 (14.2)  62 (17.4)  1.42 (0.84\u20132.40)  0.190  0.346     rs6672093          C/C  90 (27.9)  83 (23.2)  Reference       T/C  181 (56.0)  205 (57.4)  1.09 (0.73\u20131.64)  0.661  0.783     T/T  52 (16.1)  69 (19.3)  1.35 (0.80\u20132.26)  0.261  0.431     HMGA2   rs2272046          A/A  227 (68.6)  320 (88.9)  Reference       C/A  104 (31.4)  40 (11.1)  0.28 (0.18\u20130.43)  < 0.0001  < 0.0001     MTHFR   rs1801133          C/C  96 (31.3)  52 (15.5)  Reference       T/C  139 (45.3)  162 (48.2)  1.88 (1.19\u20132.96)  0.007  0.061     T/T  72 (23.5)  122 (36.3)  2.64 (1.60\u20134.34)  < 0.0001  < 0.0001     SUMO1P1   rs6022786          G/G  112 (35.0)  167 (47.7)  Reference       G/A  169 (52.8)  143 (40.9)  0.58 (0.41\u20130.84)  0.046  0.160     A/A  39 (12.2)  40 (11.4)  0.69 (0.39\u20131.21)  0.194  0.346      Boldface indicates P < 0.05; CI, confidence interval; NA, not available; OR, odds ratio; PCOS, polycystic ovarian syndrome; SNP, single-nucleotide polymorphism .   a  P value was from unconditional logistic regression with adjustment for BMI and age .   P ajusted were performed for each gene using Bonferroni correction .      Haplotype block structure and haplotype analysis  Haploview analysis indicated strong LD among SNPs in the genes CYP11A1, ESR1, ESR2, LAMC1, PGR , and PPARG (Figures 1 \u2013 3 ). In CYP11A1 , three haplotype blocks were defined using 8 genotyped SNPs. In PGR , two haplotype blocks were formed: the first spanned 17 kb and contained five tested SNPs, and the second contained three tested SNPs. In addition, ESR1, ESR2, LAMC1 , and PPARG were constructed respectively with one block. Table 5 summarizes the associations between genetic haplotypes and PCOS risk. After adjusting for age and BMI, the risk of PCOS was significantly increased among individuals carrying the haplotype \u201cCGA\u201d in Block3 of CYP11A1 (OR = 2.30, 95% CI = 1.45\u20133.66, P ajusted = 0.013), compared with those carrying the most common haplotype \u201cTAG.\u201d Similarly, the risk was also increased among individuals carrying the haplotype \u201cGTGC\u201d in ESR2 (OR = 2.01, 95% CI = 1.33\u20133.02, P ajusted = 0.020), compared with those carrying the haplotype \u201cGCAC.\u201d Furthermore, one highly protective haplotype \u201cCGCA\u201d in PPARG with 87% reduction in risk of developing PCOS comparing with those carrying the haplotype \u201cAGCA\u201d (OR = 0.13 and 95% CI = 0.04\u20130.40, P ajusted = 0.010).   Figure 1   Graphical representations of the SNP locations and LD structure of CYP11A  (A,B) and ESR1  (C,D) using tested genotyped SNPs in 331 controls.      Figure 2   Graphical representations of the SNP locations and LD structure of ESR2  (A,B) and LAMC1  (C,D) using tested genotyped SNPs in 331 controls.      Figure 3   Graphical representations of the SNP locations and LD structure of PGR  (A,B) and PPARG  (C,D) using tested genotyped SNPs in 331 controls.      Table 5   Association between CYP11A1, ESR1, ESR2, LAMC, PGR , and PPARG genetic haplotypes and PCOS risk.       Gene    Haplotype a    Frequencies    Logistic regression         Controls    Cases    OR (95% CI) b     P      P ajusted         CYP1A11     Block1  CT  0.412  0.412  1.00 (reference)  \u2013  \u2013     TC  0.421  0.403  0.96 (0.73\u20131.27)  0.779  0.874     CC  0.167  0.184  1.15 (0.81\u20131.64)  0.430  0.643    Block2     CAA  0.415  0.395  1.00 (reference)  \u2013  \u2013     CAG  0.298  0.354  1.22 (0.92\u20131.62)  0.159  0.324     GGG  0.287  0.251  0.95 (0.70\u20131.28)  0.702  0.810    Block3     TAG  0.437  0.394  1.00 (reference)  \u2013  \u2013     CAA  0.281  0.242  1.06 (0.77\u20131.45)  0.702  0.810     CAG  0.219  0.25  1.29 (0.94\u20131.79)  0.191  0.346     CGA  0.063  0.113  2.30 (1.45\u20133.66)  5*10 4   0.013      ESR1   GA  0.654  0.684  1.00 (reference)  \u2013  \u2013     AG  0.346  0.317  0.72 (0.55\u20130.93)  0.013  0.079     ESR2   GCAC  0.356  0.278  1.00 (reference)  \u2013  \u2013     CTGT  0.291  0.256  1.15 (0.84\u20131.57)  0.380  0.593     CTGC  0.234  0.26  1.34 (0.97\u20131.86)  0.074  0.214     GTGC  0.119  0.199  2.01 (1.33\u20133.02)  9*10 4   0.020      LAMC1   CTGCAAA  0.563  0.519  1.00 (reference)  \u2013  \u2013     TCATGGG  0.425  0.462  1.20 (0.93\u20131.56)  0.170  0.340     TTGCAAA  0.013  0.015  1.07 (0.38\u20133.03)  0.900  0.955     PGR     Block1  AATTG  0.884  0.838  1.00 (reference)  \u2013  \u2013     TGCCA  0.103  0.142  1.52 (1.06\u20132.20)  0.025  0.101     TGCTA  0.014  0.015  1.12 (0.41\u20133.04)  0.830  0.908    Block2  CTA  0.887  0.85  1.00 (reference)  \u2013  \u2013     ACG  0.107  0.144  1.35 (0.95\u20131.90)  0.090  0.233     PPARG      AGCA  0.515  0.616  1.00 (reference)  \u2013  \u2013     CATT  0.429  0.325  0.77 (0.59\u20131.00)  0.053  0.166     CGCA  0.048  0.006  0.13 (0.04\u20130.40)  4*10 4   0.010      CATA  0.003  0.034  10.89 (2.32\u201351.19)  0.003  0.124      Boldface indicates P < 0.05, CI, confidence interval; OR, odds ratio .   a  Polymorphic bases are listed in 5\u2032-3\u2032 order as in Figure 1 .    b  Adjusted for age and BMI. P ajusted were performed for each gene using Bonferroni correction .     In CYP11A1 , three haplotype blocks were defined using 8 genotyped SNPs. In ESR1 , one haplotype block was defined in each gene using the Haploview program with default settings. The confidence interval minima were upper 0.98 and low 0.7 in the case of strong LD; the upper confidence interval maximum was 0.9 for strong recombination; and the fraction of strong LD in informative comparisons had to be at least 0.95. SNPs are indicated by rs number (top: from left to right). (A) The numbers in squares are D\u2032 values (|D\u2032| \u00d7 100). The measure of LD (D\u2032) among all possible pairs of SNPs is shown graphically according to the shade of red, where white represents very low D\u2032 and dark red represents very high D\u2032. (B) The measure of LD ( r 2 ) among all possible pairs of SNPs is shown graphically according to the shade of gray, where white represents very low r 2 and black represents very high r 2 .  In ESR2 and LAMC1 , one haplotype block was defined in each gene using the Haploview program with default settings.  In PGR , two haplotype blocks were defined using 10 genotyped SNPs. In PPARG , one haplotype block was defined in each gene using the Haploview program with default settings.     Discussion  In this PCOS case-control study in a Chinese Han population, we found the following genotypes were associated with a lower risk of developing PCOS: GA genotype of rs9340799 in ESR1 , TA genotype of rs709154 in PPARG , and CA genotype of rs2272046 in HMGA . Conversely, the GA genotype of rs1999805 in ESR1 , and the TT genotype of rs1801133 in MTHFR were significantly associated with increased risk of PCOS. Associations of ESR1 rs9340799 ( 25 ), HMGA2 rs2272046 ( 21 ), and MTHFR rs1801133 ( 32 ) with PCOS risk have been reported in other studies. In contrast, our results appear to provide the first evidence linking rs1999805 in ESR1 and rs709154 in PPARG with PCOS risk in a Chinese population. These findings provide evidence that polymorphism in genes involved in hormonal action, lipid metabolism and insulin action may modify PCOS risk.  Polymorphism in the ESR1 gene may influence PCOS risk because the protein is necessary for the proper functioning of the hypothalamic-pituitary-ovarian axis. The protein is up-regulated in theca cells of polycystic ovaries, such that the ratio of ESR1 to ESR2 expression is elevated in PCOS, which may contribute to abnormal follicular development ( 33 ). Whatever the underlying mechanism, the association between ESR1 polymorphism and risk of PCOS appears to depend in complex ways on ethnicity. A Pakistani study linked the CC genotype of ESR1 rs2234693, the GG genotype of rs9340799, and the CT genotype of rs8179176 with elevated disease risk ( 25 ). However, studies in Greeks ( 34 ) and Caucasians ( 35 ) revealed no differences in frequencies of these genotypes between PCOS patients and controls. The present study found that the GA genotype of rs9340799 protected Chinese women from PCOS. Further study should clarify to what extent these divergent findings reflect ethnicity.  Our results raise the possibility of a correlation between polymorphism at rs1999805 in influencing PCOS risk. We found that the GA genotype of rs1999805 increased that risk in a Chinese population. Since rs1999805 lies in an ESR1 intron, the question arises whether the polymorphism contributes to disease or is simply a marker in LD with other untyped functional variants. Our LD analysis does not predict other disease-relevant sites in this gene. Therefore, the pathway(s) connecting rs1999805 polymorphism with PCOS warrant further exploration.  Our finding of a link between rs709154 and rs1151996 in PPARG , which lies in an intron of the gene, and risk of PCOS may be explained by the fact that the encoded protein functions as a nuclear hormone receptor to play a crucial role in lipogenesis, cell differentiation, inflammatory cytokine production, glucose homeostasis and insulin sensitization ( 36 ). We found evidence that PPARG rs709154 and rs1151996 acts as a protective factor against PCOS. Similarly, a meta-analysis has concluded that PPARG rs1801282 C>G polymorphism is associated with decreased PCOS risk. Conversely, the PPARG rs1801282 (Pro12Ala) polymorphism increased PCOS risk in a study comparing 100 African PCOS patients and 120 healthy controls ( 37 ). We found PPARG rs709154 to be in strong LD with rs709149 and rs709151, but we are unaware of studies investigating possible correlation among these three polymorphisms in PCOS risk. Future work should examine this question.  Our results with rs2272046 in HMGA2 are consistent with those of a previous study of 744 Han Chinese PCOS patients and 895 healthy controls linking the SNP with decreased PCOS risk ( 21 ). The polymorphism rs2272046 is located in an HMGA2 intron, raising the possibility that it affects risk of PCOS by altering degradation or translation of the HMGA2 mRNA ( 38 ). The SNP rs2272046 is in complete LD with rs74980477 (D\u2032 = 1, r 2 = 1), and the latter is predicted to alter the function of the myc gene. Normal expression of myc oncoprotein plays a critical role in initial oocyte growth and autonomous growth of granulosa cells, so dysregulation may affect follicular development ( 39 ). However, This study didn't revealed that SUMO1P1 was associated with PCOS risk, and the result was inconsistent with the GAWS studies ( 21 ). The population geographic differences, our limited power and clinical features differences in these subjects may partly explain the inconsistent results.  The results with rs1801133 in MTHFR are consistent with an Iranian study linking the CC genotype at this locus with decreased PCOS risk ( 32 ). The SNP rs1801133 occurs in an MTHFR exon that changes an Ala to Val, based on South Han Chinese data from the 1000 Genomes Project ( 40 ). This polymorphism is associated with acetylation of lysine 27 of the H3 histone protein, and this H3K27Ac mark is believed to enhance transcription, possibly by blocking the spread of the repressive histone mark H3K27Me3, which is usually found near regulatory elements and is considered to enhance transcription ( 41 ). In this way, polymorphism at rs1801133 may affect MTHFR expression and thereby affect risk of PCOS.  This study has some limitations. Our relatively small sample size limited the statistical power of our findings. We recruited only Han Chinese participants, preventing the analysis of how our SNP results depend on ethnicity. The fact that five of our 63 SNPs deviated from HWE and 5 had a minor allele frequency of 0 greatly reduced the rate of locus detection. Since our study lacked a validation group, further work is needed to confirm our observed associations between SNPs and PCOS risk.  In summary, we found, the first evidence that polymorphism at ESR1 rs1999805 and PPARG rs709154 were significantly associated with PCOS risk in Han Chinese. GA genotype at rs9340799 in ESR1 , TA genotype at rs709154 in PPARG , CA genotype at rs2272046 in HMGA2 , and GA genotype at rs6022786 in SUMO1P1 may be associated with a lower risk of developing PCOS. Conversely, GA genotype at rs1999805 in ESR1 , TT genotype at rs1801133 in MTHFR correlated with elevated PCOS risk. Our findings may help clarify the genetics of PCOS and generate leads for further functional research on the disease. Further investigations with larger, multi-ethnic samples are required to confirm our results.    Author contributions  XJ contributed significantly to analysis and wrote the manuscript. JZ and WW conceived and designed the experiments. JS and DC helped perform the analysis with constructive discussions. WC, YS, and WZ helped collect data and test specimens. XY designed the experiments and approved the final version.   Conflict of interest statement  The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",
    "tables": [
        {
            "title": "No Title",
            "content": "Characteristic    Controls ( n = 331)    Cases ( n = 361)     P a        Age (years)  28.4 \u00b1 4.2  28.1 \u00b1 3.7  0.364    BMI (kg/m 2 )  21.5 \u00b1 3.4  24.9 \u00b1 4.3  < 0.0001    < 24  282 (85.2%)  169 (46.8)     \u226524  49 (14.8%)  192 (53.2)     LH (IU/L)  4.1 \u00b1 4.7  7.0 \u00b1 5.8  < 0.0001    FSH (IU/L)  4.1 \u00b1 3.6  5.4 \u00b1 2.6   0.0002     LH/FSH  0.6 \u00b1 0.7  1.2 \u00b1 1.1  < 0.0001    T (nmol/L)  2.8 \u00b1 3.1  23.7 \u00b1 23.4  < 0.0001    E 2 (pg/ml)  88.2 \u00b1 75.3  104.7 \u00b1 165.8  0.775"
        },
        {
            "title": "No Title",
            "content": "Gene    SNP    Genomic position    Position in gene    MAF    HWE    Genotyping            Rate (%)        CYP11A1   rs9806234  74663033  Intron  0.35  0.19  96.3     rs11632698  74637867  Intron  0.25  0.47  99.2     rs11638442  74634899  Intron  0.25  0.62  99.6     rs16968478  74662811  Intron  0.45  0.12  97.2     rs1843090  74643034  Intron  0.41  0.69  96.5     rs2073475  74661894  5\u2032 near gene  0.41  0.56  97.8     rs2279357  74630623  Intron  0.41  0.56  97.4     rs4887139  74661945  5\u2032 near gene  0.1  1.00  97.2     rs7173655  74632362  Intron  0.4  0.43  97.9     CYP19A1   rs2414096  51529779  Intron  0.47  0.70  96.5     rs700518  51529112  Synonymous exon  0.47  1.00  96.7     ESR1   rs1709183  152193996  Intron  0.41  0.56  98.4     rs1801132  152265522  Synonymous exon  0.48   0.00   b    98.4     rs1884051  152283279  Intron  0.47   0.01   b    98.2     rs2228480  152420095  Intron  0.26  0.06  97.9     rs2234693  152163335  Intron  0.41  0.69  98.9     rs3020314  152270672  Intron  0.14  0.07  100.0     rs3778082  152387664  Intron  0.33  0.52  97.4     rs3778099  152418575  Intron  0.37  0.22  97.2     rs3798573  152389362  Intron  0.34  0.40  96.9     rs3798577  152421130  Intron  0.46  0.33  98.4     rs722208  152322885  Intron  0.49   0.01   b    97.8     rs851982  152024985  Intron  0.13  0.60  96.7     rs9322331  152162317  Intron  0.03  1.00  98.8     rs932477  152304596  Intron  0.39   0.01   b    99.4     rs9340799  152163381  Intron  0.19  0.61  96.9     rs1913474  152208722  Intron   0.00   a    1.00  23.4     rs1999805  152068364  Intron  0.33  0.23  97.4     rs728524  152303437  Intron  0.21   0.02   b    97.9     ESR2   rs1255998  64693871  3\u2032 utr  0.48  0.55  96.3     rs928554  64694195  3\u2032 utr  0.66  0.31  97.9     rs960070  64745179  Intron  0.25  1.00  94.3     rs1152579  64695087  Intron  0.3  0.83  96.7     rs944459  64699358  Intron  0.27  0.10  97.9     PGR   rs1042839  100922202  Synonymous exon   0.00   a    1.00  100     rs471767  100905297  3\u2032 utr  0.05  1.00  99.8     rs484389  100909809  3\u2032 utr  0.16  0.26  96.7     rs508653  100962200  Intron  0.15  0.06  98.9     rs547378  100922939  Intron  0.16  0.26  99.4     rs561650  100915894  Intron  0.14  0.69  98.4     rs566351  100985014  Intron  0.15  0.42  98.2     rs572483  100967572  Intron  0.15  0.07  97.6     rs613120  100974278  Intron  0.15  0.06  98.6     rs480851  100976191  Intron   0.00   a    1.00  98.9     rs500760  100909991  Synonymous exon  0.16  0.26  97.3     rs608995  100905733  3\u2032 utr  0.16  0.26  96.7     PPARG   rs1801282  12393125  Intron  0.06  1.00  99.1     rs1805192  12421238  Non-synonymous exon   0.00   a    1.00  100     rs709149  12450354  Intron  0.43  0.51  95.5     rs709150  12451337  Intron   0.00   a    1.00  28.2     rs709151  12454999  Intron  0.39  0.18  98.2     rs709154  12456834  Intron  0.36  0.25  98.6     rs1151996  12445807  Intron  0.47  1.00  98.2     LAMC1   rs1413390  183096634  Intron  0.45  0.55  95.9     rs1537520  183084229  Intron  0.45  0.43  98.2     rs20558  183094547  Non-synonymous exon  0.47  0.24  98.6     rs2296293  183095477  Intron  0.45  0.16  96.5     rs2296300  183099701  Intron  0.45  0.33  98.8     rs6424888  183085696  Intron  0.45  0.33  98.8     rs6672093  183079853  Intron  0.47  0.43  98.6     HMGA2   rs2272046  66224461  Intron  0.07  0.21  99.8     MTHFR   rs1801133  11856378  Non-synonymous exon  0.47  0.42  92.7     SUMO1P1   rs6022786  52447303  Intron  0.33  0.54  96.7"
        },
        {
            "title": "No Title",
            "content": "No .   Gene    SNP    Base    OR (95%CI)     P   a       P ajusted          Change          1   CYP11A1   rs9806234  G>A  1.15(0.88,1.50)  0.299  0.474    2   rs11632698  A>G  0.87(0.66,1.14)  0.311  0.479    3   rs11638442  C>G  0.89(0.67,1.17)  0.393  0.593    4   rs16968478  A>G  0.97(0.76,1.22)  0.779  0.874    5   rs1843090  G>A  0.91(0.71,1.17)  0.475  0.684    6   rs2073475  C>T  0.77(0.60,0.99)  0.042  0.150    7   rs2279357  C>T  0.91(0.71,1.17)  0.480  0.685    8   rs4887139  A>G  2.10(1.36,3.26)  0.001  0.068    9   rs7173655  C>T  0.97(0.75,1.26)  0.832  0.908    10   CYP19A1   rs2414096  G>A  1.15(0.91,1.45)  0.251  0.419    11   rs700518  T>C  1.06(0.83,1.34)  0.664  0.783    12   ESR1   rs1709183  C>T  1.02(0.79,1.31)  0.900  0.955    13   rs2228480  G>A  1.46(1.08,1.98)  0.013  0.079    14   rs2234693  T>C  1.03(0.80,1.32)  0.840  0.910    15   rs3020314  C>T  0.71(0.49,1.04)  0.081  0.218    16   rs3778082  G>A  0.76(0.58,1.00)  0.053  0.166    17   rs3778099  T>C  0.92(0.68,1.25)  0.594  0.740    18   rs3798573  A>G  0.74(0.57,0.97)  0.027  0.121    19   rs3798577  T>C  0.67(0.51,0.87)  0.003  0.124    20   rs851982  T>C  1.68(1.14,2.47)  0.008  0.218    21   rs9322331  C>T  1.46(0.70,3.04)  0.314  0.479    22   rs9340799  A>G  0.50(0.37,0.67)  0.000   0.000     23   rs1999805  G>A  1.22(0.95,1.57)  0.123  0.280    24   ESR2   rs1255998  C>G  1.05(0.83,1.33)  0.656  0.783    25   rs928554  T>C  0.83(0.63,1.08)  0.159  0.324    26   rs960070  G>C  1.36(1.01,1.84)  0.042  0.150    27   rs1152579  G>A  0.75(0.58,0.98)  0.036  0.135    28   rs944459  C>T  0.90(0.69,1.17)  0.430  0.643    29   PGR   rs471767  A>G  1.19(0.68,2.09)  0.538  0.716    30   rs484389  A>G  1.46(1.04,2.06)  0.030  0.124    31   rs508653  C>A  1.35(0.96,1.91)  0.085  0.222    32   rs547378  G>A  1.49(1.06,2.09)  0.022  0.102    33   rs561650  T>C  1.50(1.04,2.17)  0.031  0.125    34   rs566351  C>T  1.42(0.99,2.01)  0.053  0.166    35   rs572483  T>C  1.31(0.93,1.84)  0.117  0.274    36   rs613120  A>G  1.29(0.92,1.81)  0.143  0.299    37   rs500760  T>C  1.45(1.03,2.04)  0.032  0.126    38   rs608995  A>T  1.50(1.07,2.11)  0.019  0.095    39   PPARG   rs1801282  C>G  0.56(0.35,0.91)  0.020  0.095    40   rs709149  G>A  0.87(0.66,1.14)  0.311  0.479    41   rs709151  C>T  0.72(0.56,0.94)  0.017  0.092    42   rs709154  A>T  0.65(0.50,0.85)  0.001   0.013     43   rs1151996  A>C  0.66(0.51,0.85)  0.001   0.013     44   LAMC1   rs1413390  A>G  1.19(0.92,1.53)  0.191  0.346    45   rs1537520  T>C  1.19(0.92,1.55)  0.180  0.340    46   rs20558  C>T  1.18(0.91,1.53)  0.209  0.361    47   rs2296293  A>G  1.26(0.97,1.65)  0.082  0.218    48   rs2296300  A>G  1.18(0.91,1.53)  0.213  0.363    49   rs6424888  G>A  1.18(0.91,1.53)  0.204  0.356    50   rs6672093  C>T  1.15(0.89,1.49)  0.274  0.443    51   HMGA2   rs2272046  A>C  0.28(0.18,0.43)  0.000   0.000     52   MTHFR   rs1801133  T>C  0.62(0.49,0.80)  0.000   0.000     53   SUMO1P1   rs6022786  G>A  0.74(0.57,0.95)  0.019  0.095"
        },
        {
            "title": "No Title",
            "content": "Gene    SNP    Controls    Cases    OR (95%CI)     P   a       P ajusted         ( n = 331)    ( n = 361)           CYP11A1   rs9806234          G/G  124 (40.0)  139 (40.1)  Reference       G/A  156(50.3)  167 (48.1)  1.02(0.71\u20131.46)  0.926  0.974     A/A  30 (9.7)  41 (11.8)  1.50(0.83\u20132.69)  0.178  0.340     rs11632698          A/A  160 (50.2)  192 (53.6)  Reference       A/G  135 (42.3)  152 (42.5)  0.96 (0.68\u20131.36)  0.830  0.908     G/G  24 (7.5)  14 (3.9)  0.60 (0.28\u20131.25)  0.170  0.340     rs11638442          C/C  160 (50.8)  194 (53.7)  Reference       C/G  131 (41.6)  153 (42.4)  1.01 (0.71\u20131.44)  0.943  0.974     G/G  24 (7.6)  14 (3.9)  0.59 (0.28\u20131.23)  0.158  0.324     rs16968478          A/A  67 (20.6)  104 (29.7)  Reference       G/A  202 (62.0)  190 (54.3)  0.59 (0.39\u20130.88)  0.010  0.068     G/G  57 (17.5)  56 (16.0)  0.55 (0.32\u20130.94)  0.028  0.122     rs1843090          G/G  102 (32.5)  125 (35.7)  Reference       G/A  162 (51.6)  172 (49.1)  0.81 (0.56\u20131.18)  0.266  0.435     A/A  50 (15.9)  53 (15.1)  0.89 (0.53\u20131.48)  0.652  0.783     rs2073475          C/C  92 (28.3)  122 (34.7)  Reference       C/T  181 (55.7)  182 (51.7)  0.76 (0.52\u20131.10)  0.142  0.299     T/T  52 (16.0)  48 (13.6)  0.60 (0.35\u20131.01)  0.055  0.169     rs2279357          C/C  102 (30.8)  119 (34.1)  Reference       T/C  179 (54.1)  179 (51.3)  0.80 (0.55\u20131.16)  0.243  0.410     T/T  50 (15.1)  51 (14.6)  0.89 (0.53\u20131.50)  0.675  0.785     rs4887139          A/A  280 (87.2)  278 (79.0)  Reference       G/A  41 (12.8)  69 (19.6)  1.91 (1.21\u20133.04)  0.006  0.055     G/G  0 (0.0)  5 (1.4)  NA  0.977  0.980     rs7173655          C/C  101 (30.6)  113 (32.1)  Reference       C/T  186 (56.4)  189 (53.7)  0.95 (0.65\u20131.38)  0.777  0.874     T/T  43 (13.0)  50 (14.2)  0.96 (0.56\u20131.65)  0.888  0.948     CYP19A1   rs2414096          G/G  106 (34.0)  99 (28.3)  Reference       G/A  131 (42.0)  174 (49.7)  1.40 (0.94\u20132.08)  0.100  0.249     A/A  75 (24.0)  77 (22.0)  1.28 (0.80\u20132.04)  0.304  0.477     rs700518          T/T  90 (29.9)  100 (28.4)  Reference       T/C  143 (47.5)  177 (50.3)  1.05 (0.70\u20131.58)  0.801  0.892     C/C  68 (22.6)  75 (21.3)  1.11 (0.68\u20131.81)  0.668  0.783     ESR1   rs1709183          C/C  97 (29.5)  121 (34.1)  Reference       T/C  189 (57.4)  178 (50.1)  0.75 (0.52\u20131.09)  0.133  0.294     T/T  43 (13.1)  56 (15.8)  1.22 (0.72\u20132.08)  0.460  0.675     rs2228480          G/G  194 (60.8)  186 (52.4)  Reference       G/A  116 (36.4)  153 (43.1)  1.46 (1.03\u20132.07)  0.034  0.130     A/A  9 (2.8)  16 (4.5)  2.18 (0.86\u20135.55)  0.102  0.250     rs2234693          T/T  102 (32.5)  111 (30.9)  Reference       T/C  158 (50.3)  198 (55.2)  1.11 (0.76\u20131.63)  0.576  0.735     C/C  54 (17.2)  50 (13.9)  1.02 (0.61\u20131.71)  0.941  0.974     rs3020314          C/C  235 (71.0)  271 (75.1)  Reference       T/C  96 (29.0)  90 (24.9)  0.72 (0.49\u20131.04)  0.081  0.218     rs3778082          G/G  129 (42.4)  164 (46.2)  Reference       G/A  146 (48.0)  158 (44.5)  0.70 (0.48\u20131.02)  0.061  0.184     A/A  29 (9.5)  33 (9.3)  0.65 (0.34\u20131.22)  0.176  0.340     rs3778099          T/T  37 (34.9)  137 (36.9)  Reference       C/T  57 (53.8)  195 (52.6)  0.84 (0.51\u20131.49)  0.511  0.710     C/C  12 (11.3)  39 (10.5)  0.84 (0.37\u20131.86)  0.659  0.783     rs3798573          A/A  126 (40.5)  157 (44.9)  Reference       A/G  154 (49.5)  160 (45.7)  0.70 (0.49\u20131.00)  0.051  0.166     G/G  31 (10.0)  33 (9.4)  0.58 (0.31\u20131.08)  0.089  0.229     rs3798577          C/C  72 (22.4)  52 (14.5)  Reference       T/C  184 (57.3)  206 (57.5)  1.48 (0.94\u20132.33)  0.092  0.233     T/T  65 (20.2)  100 (27.9)  2.23 (1.32\u20133.78)  0.003  0.124     rs851982          T/T  266 (81.6)  258 (74.1)  Reference       T/C  60 (18.4)  83 (23.9)  1.51 (1.00\u20132.27)  0.047  0.164     C/C  0 (0.0)  7 (2.0)  NA  0.973  0.980     rs9322331          C/C  315 (96.0)  336 (94.1)  Reference       T/C  13 (4.0)  20 (5.6)  1.31 (0.60\u20132.85)  0.503  0.705     T/T  0 (0.0)  1 (0.3)  NA  0.980  0.980     rs9340799          A/A  159 (48.8)  243 (69.6)  Reference       G/A  144 (44.2)  93 (26.6)  0.40 (0.28\u20130.58)  < 0.0001  < 0.0001     G/G  23 (7.1)  13 (3.7)  0.45 (0.20\u20131.00)  0.049  0.164     rs1999805          G/G  167 (53.9)  140 (39.7)  Reference       G/A  103 (33.2)  178 (50.4)  1.91 (1.32\u20132.75)  0.001   0.013      A/A  40 (12.9)  35 (9.9)  0.98 (0.56\u20131.72)  0.953  0.978     ESR2   rs1255998          C/C  90 (29.7)  104 (29.5)  Reference       C/G  146 (48.2)  161 (45.7)  0.99 (0.66\u20131.48)  0.959  0.978     G/G  67 (22.1)  87 (24.7)  1.12 (0.70\u20131.80)  0.630  0.773     rs928554          T/T  128 (41.7)  179 (50.0)  Reference       C/T  148 (48.2)  152 (42.5)  0.89 (0.63\u20131.27)  0.523  0.716     C/C  31 (10.1)  27 (7.5)  0.60 (0.32\u20131.15)  0.124  0.280     rs960070          G/G  194 (63.8)  179 (52.5)  Reference       G/C  99 (32.6)  141 (41.3)  1.33 (0.92\u20131.91)  0.125  0.280     C/C  11 (3.6)  21 (6.2)  2.03 (0.85\u20134.85)  0.110  0.262     rs1152579          G/G  128 (40.6)  184 (52.4)  Reference       G/A  154 (48.9)  141 (40.2)  0.77 (0.54\u20131.09)  0.141  0.299     A/A  33 (10.5)  26 (7.4)  0.55 (0.29\u20131.04)  0.065  0.189     rs944459          C/C  156 (49.4)  201 (56.3)  Reference       C/T  139 (44.0)  129 (36.1)  0.77 (0.54\u20131.09)  0.136  0.297     T/T  21 (6.6)  27 (7.6)  1.06 (0.55\u20132.04)  0.868  0.933     PGR   rs471767          A/A  299 (90.3)  325 (90.3)  Reference       A/G  32 (9.7)  35 (9.7)  1.19 (0.68\u20132.09)  0.534  0.716     rs484389          A/A  262 (79.2)  248 (70.9)  Reference       A/G  61 (18.4)  95 (27.1)  1.67 (1.12\u20132.49)  0.013  0.079     G/G  8 (2.4)  7 (2.0)  1.14 (0.34\u20133.76)  0.833  0.908     rs508653          C/C  267 (81.2)  264 (73.7)  Reference       C/A  53 (16.1)  84 (23.5)  1.84 (1.20\u20132.81)  0.005  0.051     A/A  9 (2.7)  10 (2.8)  0.68 (0.25\u20131.88)  0.457  0.684     rs547378          G/G  262 (79.2)  253 (70.7)  Reference       G/A  61 (18.4)  97 (27.1)  1.69 (1.14\u20132.53)  0.010  0.068     A/A  8 (2.4)  8 (2.2)  1.22 (0.38\u20133.87)  0.735  0.836     rs561650          T/T  265 (80.1)  262 (74.0)  Reference       T/C  64 (19.3)  85 (24.0)  1.44 (0.96\u20132.15)  0.077  0.216     C/C  2 (0.6)  7 (2.0)  3.33 (0.59\u201318.9)  0.174  0.340     rs566351          C/C  260 (79.5)  256 (72.1)  Reference       C/T  62 (19.0)  89 (25.1)  1.51 (1.00\u20132.27)  0.049  0.164     T/T  5 (1.5)  10 (2.8)  1.46 (0.44\u20134.85)  0.538  0.716     rs572483          T/T  263 (79.9)  259 (73.4)  Reference       C/T  57 (17.3)  83 (23.5)  1.70 (1.12\u20132.58)  0.013  0.079     C/C  9 (2.7)  11 (3.1)  0.76 (0.28\u20132.05)  0.588  0.739     rs613120          A/A  265 (80.1)  262 (73.8)  Reference       A/G  57 (17.2)  82 (23.1)  1.66 (1.09\u20132.52)  0.017  0.092     G/G  9 (2.7)  11 (3.1)  0.75 (0.28\u20132.01)  0.561  0.734     rs500760          T/T  262 (79.2)  247 (70.6)  Reference       C/T  61 (18.4)  95 (27.1)  1.63 (1.09\u20132.44)  0.017  0.092     C/C  8 (2.4)  8 (2.3)  1.25 (0.39\u20133.99)  0.702  0.810     rs608995          A/A  258 (78.9)  244 (69.7)  Reference       T/A  61 (18.7)  98 (28.0)  1.71 (1.15\u20132.56)  0.008  0.063     T/T  8 (2.4)  8 (2.3)  1.24 (0.39\u20133.93)  0.711  0.815     PPARG   rs1801282          C/C  271 (83.4)  321 (89.2)  Reference       C/G  54 (16.6)  39 (10.8)  0.56 (0.35\u20130.91)  0.020  0.095     rs709149          G/G  95 (30.0)  132 (37.9)  Reference       G/A  177 (55.8)  176 (50.6)  0.73 (0.50\u20131.07)  0.108  0.261     A/A  45 (14.2)  40 (11.5)  0.86 (0.48\u20131.54)  0.621  0.768     rs709151          C/C  85 (26.2)  133 (37.6)  Reference       T/C  189 (58.3)  182 (51.4)  0.61 (0.42\u20130.89)  0.009  0.067     T/T  50 (15.4)  39 (11.0)  0.60 (0.34\u20131.04)  0.069  0.197     rs709154          A/A  90 (27.5)  156 (43.9)  Reference       T/A  187 (57.2)  160 (45.1)  0.47 (0.33\u20130.69)  < 0.0001  < 0.0001     T/T  50 (15.3)  39 (11.0)  0.54 (0.31\u20130.94)  0.030  0.124     rs1151996          A/A  88 (27.2)  125 (35.9)  Reference       C/A  154 (47.7)  182 (52.3)  0.81 (0.55\u20131.19)  0.285  0.457     C/C  81 (25.1)  41 (11.8)  0.40 (0.24\u20130.68)  0.010  0.068     LAMC1   rs1413390          A/A  97 (30.5)  88 (25.4)  Reference       G/A  174 (54.7)  195 (56.4)  1.14 (0.77\u20131.70)  0.501  0.705     G/G  47 (14.8)  63 (18.2)  1.43 (0.85\u20132.40)  0.184  0.344     rs1537520          T/T  97 (29.5)  88 (24.8)  Reference       C/T  185 (56.2)  206 (58.0)  1.15 (0.78\u20131.71)  0.473  0.684     C/C  47 (14.3)  61 (17.2)  1.44 (0.85\u20132.44)  0.174  0.34     rs20558          C/C  96 (29.2)  88 (24.6)  Reference       T/C  187 (56.8)  208 (58.3)  1.12 (0.75\u20131.65)  0.585  0.739     T/T  46 (14.0)  61 (17.1)  1.42 (0.84\u20132.41)  0.192  0.346     rs2296293          A/A  97 (30.1)  87 (25.0)  Reference       A/G  183 (56.8)  201 (57.8)  1.13 (0.76\u20131.69)  0.536  0.716     G/G  42 (13.0)  60 (17.2)  1.67 (0.97\u20132.86)  0.065  0.189     rs2296300          A/A  97 (29.3)  89 (25.0)  Reference       A/G  187 (56.5)  206 (57.9)  1.12 (0.76\u20131.66)  0.570  0.735     G/G  47 (14.2)  61 (17.1)  1.41 (0.83\u20132.39)  0.199  0.351     rs6424888          G/G  97 (29.3)  88 (24.6)  Reference       G/A  187 (56.5)  207 (58.0)  1.12 (0.76\u20131.66)  0.559  0.734     A/A  47 (14.2)  62 (17.4)  1.42 (0.84\u20132.40)  0.190  0.346     rs6672093          C/C  90 (27.9)  83 (23.2)  Reference       T/C  181 (56.0)  205 (57.4)  1.09 (0.73\u20131.64)  0.661  0.783     T/T  52 (16.1)  69 (19.3)  1.35 (0.80\u20132.26)  0.261  0.431     HMGA2   rs2272046          A/A  227 (68.6)  320 (88.9)  Reference       C/A  104 (31.4)  40 (11.1)  0.28 (0.18\u20130.43)  < 0.0001  < 0.0001     MTHFR   rs1801133          C/C  96 (31.3)  52 (15.5)  Reference       T/C  139 (45.3)  162 (48.2)  1.88 (1.19\u20132.96)  0.007  0.061     T/T  72 (23.5)  122 (36.3)  2.64 (1.60\u20134.34)  < 0.0001  < 0.0001     SUMO1P1   rs6022786          G/G  112 (35.0)  167 (47.7)  Reference       G/A  169 (52.8)  143 (40.9)  0.58 (0.41\u20130.84)  0.046  0.160     A/A  39 (12.2)  40 (11.4)  0.69 (0.39\u20131.21)  0.194  0.346"
        },
        {
            "title": "No Title",
            "content": "Gene    Haplotype a    Frequencies    Logistic regression         Controls    Cases    OR (95% CI) b     P      P ajusted         CYP1A11     Block1  CT  0.412  0.412  1.00 (reference)  \u2013  \u2013     TC  0.421  0.403  0.96 (0.73\u20131.27)  0.779  0.874     CC  0.167  0.184  1.15 (0.81\u20131.64)  0.430  0.643    Block2     CAA  0.415  0.395  1.00 (reference)  \u2013  \u2013     CAG  0.298  0.354  1.22 (0.92\u20131.62)  0.159  0.324     GGG  0.287  0.251  0.95 (0.70\u20131.28)  0.702  0.810    Block3     TAG  0.437  0.394  1.00 (reference)  \u2013  \u2013     CAA  0.281  0.242  1.06 (0.77\u20131.45)  0.702  0.810     CAG  0.219  0.25  1.29 (0.94\u20131.79)  0.191  0.346     CGA  0.063  0.113  2.30 (1.45\u20133.66)  5*10 4   0.013      ESR1   GA  0.654  0.684  1.00 (reference)  \u2013  \u2013     AG  0.346  0.317  0.72 (0.55\u20130.93)  0.013  0.079     ESR2   GCAC  0.356  0.278  1.00 (reference)  \u2013  \u2013     CTGT  0.291  0.256  1.15 (0.84\u20131.57)  0.380  0.593     CTGC  0.234  0.26  1.34 (0.97\u20131.86)  0.074  0.214     GTGC  0.119  0.199  2.01 (1.33\u20133.02)  9*10 4   0.020      LAMC1   CTGCAAA  0.563  0.519  1.00 (reference)  \u2013  \u2013     TCATGGG  0.425  0.462  1.20 (0.93\u20131.56)  0.170  0.340     TTGCAAA  0.013  0.015  1.07 (0.38\u20133.03)  0.900  0.955     PGR     Block1  AATTG  0.884  0.838  1.00 (reference)  \u2013  \u2013     TGCCA  0.103  0.142  1.52 (1.06\u20132.20)  0.025  0.101     TGCTA  0.014  0.015  1.12 (0.41\u20133.04)  0.830  0.908    Block2  CTA  0.887  0.85  1.00 (reference)  \u2013  \u2013     ACG  0.107  0.144  1.35 (0.95\u20131.90)  0.090  0.233     PPARG      AGCA  0.515  0.616  1.00 (reference)  \u2013  \u2013     CATT  0.429  0.325  0.77 (0.59\u20131.00)  0.053  0.166     CGCA  0.048  0.006  0.13 (0.04\u20130.40)  4*10 4   0.010      CATA  0.003  0.034  10.89 (2.32\u201351.19)  0.003  0.124"
        }
    ],
    "images": [
        {
            "caption": "Graphical representations of the SNP locations and LD structure of CYP11A  (A,B) and ESR1  (C,D) using tested genotyped SNPs in 331 controls."
        },
        {
            "caption": "Graphical representations of the SNP locations and LD structure of ESR2  (A,B) and LAMC1  (C,D) using tested genotyped SNPs in 331 controls."
        },
        {
            "caption": "Graphical representations of the SNP locations and LD structure of PGR  (A,B) and PPARG  (C,D) using tested genotyped SNPs in 331 controls."
        }
    ]
}